OptimizeRx Corporation increased earnings guidance for the year 2023. For the year, the company now expects revenue to be between $68 million and $70 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.81 USD | -0.92% | +1.79% | -24.46% |
29/04 | OptimizeRx Corporation Provides Earnings Guidance for the First Quarter of 2024 | CI |
16/04 | Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 Revenue $28.4M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.46% | 197M | |
+28.20% | 441B | |
+25.47% | 263B | |
+8.80% | 140B | |
+7.48% | 92.89B | |
+25.85% | 90.53B | |
+56.78% | 58.64B | |
+16.13% | 46.96B | |
+2.85% | 36.7B | |
+20.84% | 36.11B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- OptimizeRx Corporation Increases Earnings Guidance for the Year 2023